2-(Arabinosylamino)-3-(glucosylamino)propanenitrile

Metabolite details

Identifier

BTGYSUHNSKOEKC-UHFFFAOYSA-N

InChI Key

BTGYSUHNSKOEKC-UHFFFAOYSA-N

IUPAC name

3-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]amino]-2-[(3,4,5-trihydroxyoxan-2-yl)amino]propanenitrile

Preferred name

2-(Arabinosylamino)-3-(glucosylamino)propanenitrile

INN name

—

Synonym

—

ChEBI

CHEBI:175872

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Hfq Regulates Efflux Pump Expression and Purine Metabolic Pathway to Increase the Trimethoprim Resistance in Aeromonas veronii
• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
• Intergenerational Association of Gut Microbiota and Metabolism between Perinatal Folic Acid Metabolism and Neural Tube Defects (Feces metabolomics)
• Interaction between Cervical Microbiota and Host Gene Regulation in Caesarean Section Scar Diverticulum
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
• Alterations in the gut microbiota and metabolomics of seafarers after a six-month sea voyage
• Disturbed Microbiota-Metabolites-Immune Interaction Network is Associated with Olfactory Dysfunction in Patients with Chronic Rhinosinusitis

Observed in differential profiles

• Wild_type_vs_hfq
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• G1_PBS_vs_G2_DSS
• Normal_vs_Neural_Tube_Defect
• Control_vs_CSD
• Control_vs_ZYP_High_Dose
• Control_0d_vs_Treatment_180d
• Control_0d_vs_Treatment_180d
• Normal_vs_Abnormal